Page results
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
Information on safer eating during treatment, for patients with blood cancer.
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
Health and wellbeing information for people affected by cancer.
-
Health and wellbeing information for people affected by cancer.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
All HPB and hepatology clinical and academic services, including pancreatic cancer services, have transferred from UCLH to the Royal Free Hampstead NHS Trust, creating one of the largest centres in Europe for the treatment of conditions of the liver, pancreas and biliary system.
File results
-
FOI/2024/0295 - MRI scanners at Trust 2019/2020 and 2022/24
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0301 - Nursing associates and trainee nursing associates policy
-
FOI/2024/0302 - Mental health diagnosis for patients aged 11 to 25
-
FOI/2024/0303 - Lost histology (histopathology) specimens/ sample tracking systems
-
FOI/2024/0308 - Misuse of Electronic Patient Record systems (EPRS)
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases